FDA Panel Endorses ‘Female Viagra’

A Food and Drug Administration panel voted Thursday to recommend the first-ever “female Viagra” pill. The benefits of the drug, flibaneserin, have only been described as “moderate” or “marginal,” but committee members said that even a moderate benefit is better than nothing for women who suffer from hypoactive sexual desire disorder. The FDA has already rejected the drug twice on the grounds that its potential side effects—fainting, nausea, dizziness, sleepiness, and low-blood pressure—outweigh the benefits.